144 results
Page 3 of 8
424B5
plj7098na1y
29 Mar 12
Prospectus supplement for primary offering
12:00am
424B5
gvm589e h04pi
29 Mar 12
Prospectus supplement for primary offering
12:00am
8-K
EX-99.3
bo50ro66
6 Jan 12
NeoStem, Inc. (“NBS”) Investor Presentation January 2012
12:00am
8-K
EX-4.1
man69r2u1 xjsk89w
17 Oct 11
NeoStem Acquires Amorcyte, a Clinical Stage Cardiovascular Disease Cell Therapy Company
12:00am
424B5
aaquwnzi kfcdp
30 Sep 11
Prospectus supplement for primary offering
12:00am
424B3
5133x
16 Sep 11
Prospectus supplement
12:00am
425
EX-4.1
qro4mrgx
20 Jul 11
Business combination disclosure
12:00am
424B5
m24jgo2yopdp7 64uor
20 Jul 11
Prospectus supplement for primary offering
12:00am
8-K
EX-4.1
e3gxbb51y
20 Jul 11
NeoStem Announces Pricing of Public Offering for $16,500,000 in Gross Proceeds
12:00am
424B5
momkpd
18 Jul 11
Prospectus supplement for primary offering
12:00am
8-K
s18wpywn59215cgtd
14 Jul 11
Entry into a Material Definitive Agreement
12:00am
425
EX-2.1
jh1x63r0zh lex
14 Jul 11
Business combination disclosure
12:00am
8-K
EX-2.1
r1lrg 5qxd1l8xb20
14 Jul 11
Entry into a Material Definitive Agreement
12:00am
425
zovmhja1uxep8 k632
14 Jul 11
Business combination disclosure
12:00am